IDEAYA Biosciences Files 8-K
Ticker: IDYA · Form: 8-K · Filed: Oct 4, 2024 · CIK: 1676725
| Field | Detail |
|---|---|
| Company | Ideaya Biosciences, Inc. (IDYA) |
| Form Type | 8-K |
| Filed Date | Oct 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
IDEAYA filed a standard 8-K on Oct 4th, nothing major detailed here.
AI Summary
IDEAYA Biosciences, Inc. filed an 8-K on October 4, 2024, reporting other events and financial statements. The filing does not contain specific details about new events or financial figures within the provided text, but indicates a standard regulatory update.
Why It Matters
This filing is a routine regulatory disclosure by IDEAYA Biosciences, Inc. to the SEC, indicating updates or events relevant to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K, which typically contains standard disclosures and does not inherently signal significant new risks.
Key Players & Entities
- IDEAYA Biosciences, Inc. (company) — Registrant
- October 4, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-38915 (identifier) — Commission File Number
- 47-4268251 (identifier) — IRS Employer Identification Number
- 5000 Shoreline Court, Suite 300 (address) — Principal Executive Offices
- South San Francisco, California 94080 (address) — Principal Executive Offices
- (650) 443-6209 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by IDEAYA Biosciences, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of October 4, 2024.
On what date was this 8-K filing reported?
This 8-K filing was reported on October 4, 2024.
In which state is IDEAYA Biosciences, Inc. incorporated?
IDEAYA Biosciences, Inc. is incorporated in Delaware.
What is the Commission File Number for IDEAYA Biosciences, Inc.?
The Commission File Number for IDEAYA Biosciences, Inc. is 001-38915.
What is the address of IDEAYA Biosciences, Inc.'s principal executive offices?
The address of IDEAYA Biosciences, Inc.'s principal executive offices is 5000 Shoreline Court, Suite 300, South San Francisco, California 94080.
Filing Stats: 470 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-10-04 16:01:59
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IDYA The Nasdaq
Filing Documents
- d828798d8k.htm (8-K) — 25KB
- d828798dex991.htm (EX-99.1) — 9KB
- g828798g1004111012156.jpg (GRAPHIC) — 2KB
- 0001193125-24-233038.txt ( ) — 159KB
- idya-20241004.xsd (EX-101.SCH) — 3KB
- idya-20241004_lab.xml (EX-101.LAB) — 18KB
- idya-20241004_pre.xml (EX-101.PRE) — 11KB
- d828798d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following exhibits are filed with this report: Exhibit No. Description 99.1 Press Release announcing Late-Breaking Oral Presentation of IDE397 Phase 1 Expansion Results in MTAP-Deletion Lung and Urothelial Cancer at the 36 th Edition of the EORTC-NCI-AACR Symposium. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEAYA BIOSCIENCES, INC. Date: October 4, 2024 By: /s/ Yujiro Hata Yujiro Hata President and Chief Executive Officer